Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01277770 · ClinicalTrials.gov registry record

Studies of Kidney Transplant Outcome

A clinical trial of Transplant Recipient (Kidney) and Steroid-Free Maintenance Immunosuppression, sponsored by University of Minnesota.

Completed
Registry status
7,500
Enrollment target
1
Study location

NCT01277770 is a study of Transplant Recipient (Kidney) and Steroid-Free Maintenance Immunosuppression that has completed, run by University of Minnesota. The registered enrollment target is 7,500 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01277770, a study of Transplant Recipient (Kidney) and Steroid-Free Maintenance Immunosuppression, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
7,500 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to improve outcome for kidney transplant recipients. There has not been commensurate improvement in medium and long-term outcomes. Ongoing clinical research is necessary to improve transplant outcomes.

Interventions

  • DRUG Steroid-Free Maintenance Immunosuppression
  • OTHER Infection After Kidney Transplantation
  • DRUG Evaluation of the DGF nomogram in Thymoglobulin

Study Locations (1)

Minnesota

  • University Of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 7,500 participants
Start Date 2009-05
Est. Completion 2019-05-06

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT01277770

The ClinicalTrials.gov registry entry for NCT01277770 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Transplant Recipient (Kidney) appearing as the primary indexed condition, and to 3 interventions - of which Steroid-Free Maintenance Immunosuppression is the first listed.

NCT01277770 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT01277770 about?

NCT01277770 is a clinical study titled "Studies of Kidney Transplant Outcome". The purpose of this study is to improve outcome for kidney transplant recipients. There has not been commensurate improvement in medium and long-term outcomes. Ongoing clinical research is necessary to improve transplant outcomes.

What is the current status of trial NCT01277770?

This trial is currently completed. The enrollment target is 7,500 participants. The study started on 2009-05. Estimated completion is 2019-05-06.

What conditions does trial NCT01277770 study?

This clinical trial studies the following conditions: Transplant Recipient (Kidney), Steroid-Free Maintenance Immunosuppression, Post-Transplant Infections, Thymoglobulin.

What interventions are being tested in trial NCT01277770?

The interventions under investigation include: Steroid-Free Maintenance Immunosuppression (DRUG), Infection After Kidney Transplantation (OTHER), Evaluation of the DGF nomogram in Thymoglobulin (DRUG).

Who is sponsoring clinical trial NCT01277770?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01277770 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Transplant Recipient (Kidney)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.